Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration
Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older
Varicella zoster virus vaccine live
Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom
Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine
The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity
Varicella-zoster-virus-vaccine-live